Tags » William Ackman

Valeant Pharmaceuticals faces tough choices in asset sales: Retire debt or give up cash flow

NEW YORK — As Valeant Pharmaceuticals considers a multi-billion-dollar auction to pare down US$30 billion in debt, its challenge will be choosing which assets to sell without compromising any of its key businesses, analysts and investment bankers said. 785 more words

Market Moves

Teva in talks to buy Allergan's generic drug business

Teva Pharmaceutical Industries Ltd is in advanced talks to buy Allergan Plc’s generic drug business following a thus far unsuccessful effort to acquire peer Mylan NV, according to a person familiar with the matter. 359 more words

Finance

Another activist investor takes on Macy's this time

Starboard Value Investors garnered a lot of PR recently, with its micro-critical look at the operations of Darden Restaurants before taking over the chain. Now its sights are set on Macy’s, in hopes to “unlock the asset value” of Macy’s real estate. 151 more words

Dick Seesel